Electronic medical records-based comparison of glycemic control efficacy between sulfonylureas and dipeptidyl peptidase-4 inhibitors added on to metformin monotherapy in patients with type 2 diabetes

Sulfonylurea (SU) and dipeptidyl peptidase-4 (DPP-4) inhibitors are most common secondary agents that are added to metformin monotherapy. Real-world studies have become increasingly important in providing evidence of treatment effectiveness in clinical practice and real-world data could help appropr...

Descripción completa

Detalles Bibliográficos
Autores principales: Lee, Suhrin, Lee, SeungHwan, Jang, In-Jin, Yu, Kyung-Sang, Rhee, Su-jin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Korean Society for Clinical Pharmacology and Therapeutics 2020
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7781806/
https://www.ncbi.nlm.nih.gov/pubmed/33425803
http://dx.doi.org/10.12793/tcp.2020.28.e21

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7781806/
https://www.ncbi.nlm.nih.gov/pubmed/33425803
http://dx.doi.org/10.12793/tcp.2020.28.e21

Ejemplares similares